GSK Plc CEO Emma Walmsley talks about buying US cancer biotech IDRx for as much as $1.15 billion, expanding their portfolio in the US, their overall drug pipeline and working with Robert F. Kennedy Jr., President-elect Donald Trump's choice to lead the Department of Health and Human Services. She speaks from the JPMorgan Healthcare Conference.

Bloomberg videos, provided by MT Newswires